BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20466963)

  • 1. Application of a system dynamics model to inform investment in smoking cessation services in New Zealand.
    Tobias MI; Cavana RY; Bloomfield A
    Am J Public Health; 2010 Jul; 100(7):1274-81. PubMed ID: 20466963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass media promotion of a smartphone smoking cessation app: modelled health and cost-saving impacts.
    Nghiem N; Leung W; Cleghorn C; Blakely T; Wilson N
    BMC Public Health; 2019 Mar; 19(1):283. PubMed ID: 30849943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricting tobacco sales to only pharmacies combined with cessation advice: a modelling study of the future smoking prevalence, health and cost impacts.
    Petrović-van der Deen FS; Blakely T; Kvizhinadze G; Cleghorn CL; Cobiac LJ; Wilson N
    Tob Control; 2019 Nov; 28(6):643-650. PubMed ID: 30413563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of public policies in reducing smoking: the Minnesota SimSmoke tobacco policy model.
    Levy DT; Boyle RG; Abrams DB
    Am J Prev Med; 2012 Nov; 43(5 Suppl 3):S179-86. PubMed ID: 23079215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008.
    Lightwood J; Glantz SA
    PLoS One; 2013; 8(2):e47145. PubMed ID: 23418411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projecting the effects of tobacco control policies in the USA through microsimulation: a study protocol.
    Tam J; Levy DT; Jeon J; Clarke J; Gilkeson S; Hall T; Feuer EJ; Holford TR; Meza R
    BMJ Open; 2018 Mar; 8(3):e019169. PubMed ID: 29574440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Zealand's tobacco control programme 1985-1998.
    Laugesen M; Swinburn B
    Tob Control; 2000 Jun; 9(2):155-62. PubMed ID: 10841851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential effects of tobacco control in China: projections from the China SimSmoke simulation model.
    Levy D; Rodríguez-Buño RL; Hu TW; Moran AE
    BMJ; 2014 Feb; 348():g1134. PubMed ID: 24550245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tobacco control scenarios: quantifying estimates of long-term health impact using the DYNAMO-HIA modeling tool.
    Kulik MC; Nusselder WJ; Boshuizen HC; Lhachimi SK; Fernández E; Baili P; Bennett K; Mackenbach JP; Smit HA
    PLoS One; 2012; 7(2):e32363. PubMed ID: 22384230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance for selected tobacco-use behaviors--United States, 1900-1994.
    Giovino GA; Schooley MW; Zhu BP; Chrismon JH; Tomar SL; Peddicord JP; Merritt RK; Husten CG; Eriksen MP
    MMWR CDC Surveill Summ; 1994 Nov; 43(3):1-43. PubMed ID: 7969014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of tobacco control policies on smoking prevalence and smoking-attributable deaths in Ireland using the IrelandSS simulation model.
    Currie LM; Blackman K; Clancy L; Levy DT
    Tob Control; 2013 May; 22(e1):e25-32. PubMed ID: 22634570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building and Scaling-up California Quits: Supporting Health Systems Change for Tobacco Treatment.
    Kaslow AA; Romano PS; Schwarz E; Shaikh U; Tong EK
    Am J Prev Med; 2018 Dec; 55(6 Suppl 2):S214-S221. PubMed ID: 30454676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco control policy in the UK: blueprint for the rest of Europe?
    Levy DT; Currie L; Clancy L
    Eur J Public Health; 2013 Apr; 23(2):201-6. PubMed ID: 22826505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016.
    Max W; Sung HY; Lightwood J
    Tob Control; 2013 May; 22(e1):e10-5. PubMed ID: 22253003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population.
    Reddy KP; Bulteel AJB; Levy DE; Torola P; Hyle EP; Hou T; Osher B; Yu L; Shebl FM; Paltiel AD; Freedberg KA; Weinstein MC; Rigotti NA; Walensky RP
    BMJ Open; 2020 May; 10(5):e032579. PubMed ID: 32404384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the number of quitters needed to achieve New Zealand's Smokefree 2025 goal for Māori and non-Māori.
    Wilson N; Petrović-van der Deen FS; Edwards R; Waa A; Blakely T
    N Z Med J; 2018 Dec; 131(1487):30-37. PubMed ID: 30543609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SimSmoke model evaluation of the effect of tobacco control policies in Korea: the unknown success story.
    Levy DT; Cho SI; Kim YM; Park S; Suh MK; Kam S
    Am J Public Health; 2010 Jul; 100(7):1267-73. PubMed ID: 20466968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Support for a tobacco endgame and increased regulation of the tobacco industry among New Zealand smokers: results from a National Survey.
    Edwards R; Wilson N; Peace J; Weerasekera D; Thomson GW; Gifford H
    Tob Control; 2013 May; 22(e1):e86-93. PubMed ID: 22535362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gauging the Effect of U.S. Tobacco Control Policies From 1965 Through 2014 Using SimSmoke.
    Levy DT; Meza R; Zhang Y; Holford TR
    Am J Prev Med; 2016 Apr; 50(4):535-542. PubMed ID: 26673484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.
    Popp J; Nyman JA; Luo X; Bengtson J; Lust K; An L; Ahluwalia JS; Thomas JL
    Eur J Health Econ; 2018 Dec; 19(9):1319-1333. PubMed ID: 29687268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.